Skip to main content
Addgene

Highly efficient generation of isogenic pluripotent stem cell models using prime editing.

Li H, Busquets O, Verma Y, Syed KM, Kutnowski N, Pangilinan GR, Gilbert LA, Bateup HS, Rio DC, Hockemeyer D, Soldner F
Elife. 2022 Sep 7;11:e79208. doi: 10.7554/eLife.79208. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
180014AAVS1-SA-neo-CAGGS-PE2-2A-GFPTargeting vector for knocking in constitutively expressed PE2-2A-GFP into the human AAVS1 locus
180015pET30a(+)-PE2Expressing PE2 protein in E.coli for protein purification
180016pU6-pegRNA-SNCA-A30PTransiently expressing a pegRNA to introduce SNCA-A30P mutation in human cells
180017pU6-pegRNA-HEK3-CTTins-px330-scaffoldTransiently expressing a pegRNA to introduce HEK3 CTT insertion in human cells. It has a sgRNA scaffold from px330.
180018pBPK1520-SNCA-A30P-ngTransiently expressing a nicking sgRNA to facilitate the introduction of SNCA-A30P mutation in PE3 approach
180019pBPK1520-HEK3-CTTins-ngTransiently expressing a nicking sgRNA to facilitate the introduction of HEK3 CTT insertion in PE3 approach
180432pU6-pegRNA-LRRK2-G2019S-3aTransiently expressing a pegRNA to introduce LRRK2-G2019S mutation in human cells
180433pU6-pegRNA-LRRK2-G2019S-3bTransiently expressing a pegRNA to introduce LRRK2-G2019S mutation in human cells
180434pU6-pegRNA-LRRK2-G2019S-3cTransiently expressing a pegRNA to introduce LRRK2-G2019S mutation in human cells
180435pU6-pegRNA-LRRK2-G2019S-3dTransiently expressing a pegRNA to introduce LRRK2-G2019S mutation in human cells
180436BPK1520-LRRK2-G2019S-ngTransiently expressing a nicking sgRNA to facilitate the introduction of LRRK2-G2019S mutation in PE3 approach
180437Px330-EGFP-LRRK2-CRISPR/Cas9Plasmid to express Cas9 from S.pyogenesand CRISPR gRNA to introduce LRRK2-G2019S mutation in human cells
181738pU6-pegRNA-SNCA-A53TTransiently expressing a pegRNA to introduce SNCA-A53T mutation in human cells
181739pBPK1520-SNCA-A53T-ngTransiently expressing a nicking sgRNA to facilitate the introduction of SNCA-A53T mutation in PE3 approach

Antibodies from Article